HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wellness (Dietary Supplements)

Set Alert for Wellness

Regulation / Legislation Explore this Topic

Set Alert for Regulation and Legislation {Wellness}

Latest From Regulation & Wellness

US FDA Implementing Hybrid Work Policy In January

Agency employees will have on-site, telework and remote possibilities, but options will depend on the center, office and job duties.

FDA Coronavirus COVID-19

Europe's Botanicals Deadlock ‘Unlawful,’ Claims Industry Lawyer

The European Commission’s obvious passivity” with regards to the long-standing botanical health claims deadlock is illegal and violates the provisions of the EU Health Claims Regulation,” argues the German Pharmaceutical Industry Association, on the basis of a legal opinion provided by former constitutional judge Udo Di Fabio.

Europe Germany

‘General Benefit’ Insufficient For EU Food For Special Medical Purposes Classification

In a case that could have far-reaching implications for the region's food supplement manufacturers, the European Court of Justice has ruled that the definition of foods for special medical purposes should be restricted to use in addressing a specific nutrient deficiency related to an illness, as defined by EU law.

Europe Germany
See All

Latest From Legislation & Wellness

Europe's Botanicals Deadlock ‘Unlawful,’ Claims Industry Lawyer

The European Commission’s obvious passivity” with regards to the long-standing botanical health claims deadlock is illegal and violates the provisions of the EU Health Claims Regulation,” argues the German Pharmaceutical Industry Association, on the basis of a legal opinion provided by former constitutional judge Udo Di Fabio.

Europe Germany

Still No Appetite At US FDA For CBD In Food

Three years after similar warnings to make same impression, FDA warns five firms about using in food or beverage products CBD, the cannabinoid most commonly found in US, and delta-8 THC, a subject of ongoing discussion over whether it qualifies as hemp. One firm also warned about CBD in sunscreen.

Cannabidiol CBD FDA

Study Finds Data Scarce Where US FDA Wants To Gauge Hemp Safety – Reproductive Toxicity

First systematic mapping study of safety concerns for consumer use of cannabidiol identifies knowledge gaps for reproductive and developmental toxicity. No traditional, guideline-compliant developmental and reproductive toxicity study was available in the public domain through December 2020.

Cannabidiol CBD FDA
See All

Business Explore this Topic

Set Alert for Business {Wellness}

Latest From Deals & Wellness

Viatris Puts OTC Business Up For Sale

Viatris has decided to exit the consumer health market and has put up for sale an OTC business which is thought to generate around $1.0bn in annual sales.

Business Strategies Health

Haleon Establishing Own Distribution In India To Unleash Growth

Haleon is taking back full control of its interests in India by terminating a distribution deal for its OTC and oral care brands signed with Hindustan Unilever in 2020.

Business Strategies India

Alfasigma Signals Consumer Health Ambitions With Sofar Acquisition

By acquiring fellow Italian manufacturer Sofar, Alfasigma expands its consumer health footprint and adds products and expertise in its priority gastrointestinal category.

Deals Business Strategies
See All

Latest From Business Strategies & Wellness

OTC Marketing Awards 2022: What The Judges Said About The Leading Entries

The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?

Innovation Ad Campaigns

Haleon Voted Company Of The Year At The OTC Marketing Awards 2022

Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.

Ad Campaigns Launches

Nestlé Discovers Gut Bacteria Strain Suggesting Opportunities For Infant Nutrition

Scientists at Nestlé’s research division think that they have found new bifidobacterium longum strains that have unique ability to utilize both key components of human milk and fibers from solid food, opening up new opportunities for “next generation nutritional solutions” like probiotics targeting the crucial weaning period of child development.

International Wellness
See All

Latest From Sales & Earnings & Wellness

Germany's PharmaSGP Raises Sales Guidance In 'Record Year'

European Consumer health player PharmaSGP is well on the way to achieving new record revenues in 2022, and is working to maintain this upward trajectory over the medium and long term. 

Europe Health

Taisho Boosted By Overseas Sales With Japanese Business Flat

Taisho's Self-Medication business posted a solid gain in the six months ended 30 September as a recovery in its Overseas operation boosted a flat performance in Japan.

Japan Europe

Haleon Raises Sales Guidance But Warns Of Tougher Q4

While Haleon expects 2022 sales to grow by around 8%, the UK-based consumer health giant faces a more difficult end to the year as it begins to cycle over significant price increases rolled out towards the end of 2021.

Sales & Earnings OTC Drugs
See All

Latest From Legal Issues & Wellness

Europe's Botanicals Deadlock ‘Unlawful,’ Claims Industry Lawyer

The European Commission’s obvious passivity” with regards to the long-standing botanical health claims deadlock is illegal and violates the provisions of the EU Health Claims Regulation,” argues the German Pharmaceutical Industry Association, on the basis of a legal opinion provided by former constitutional judge Udo Di Fabio.

Europe Germany

‘General Benefit’ Insufficient For EU Food For Special Medical Purposes Classification

In a case that could have far-reaching implications for the region's food supplement manufacturers, the European Court of Justice has ruled that the definition of foods for special medical purposes should be restricted to use in addressing a specific nutrient deficiency related to an illness, as defined by EU law.

Europe Germany

Ginkgo Biloba Extract Is Drug, Not Supplement, Rules German Supreme Court

Products containing “monograph compliant” ginkgo biloba dry extract as the main active ingredient at recommended doses of 100mg per day should be considered drugs, not dietary supplements, Germany’s federal administrative court has ruled. The decision settles a longstanding dispute between the country’s food regulator and an unnamed company that had applied for registration of such a product.

Germany Wellness
See All

Marketing Explore this Topic

Set Alert for Marketing {Wellness}

Latest From Launches & Wellness

OTC Marketing Awards 2022: What The Judges Said About The Leading Entries

The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?

Innovation Ad Campaigns

Haleon Voted Company Of The Year At The OTC Marketing Awards 2022

Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.

Ad Campaigns Launches

OTC Marketing Awards 2022 Just One Week Away

Don’t miss out on your chance to attend the OTC Marketing Awards 2022 in London on 28 November. Join us in celebrating innovation and creativity in the British consumer health industry.

United Kingdom Health
See All

Latest From Ad Campaigns & Wellness

OTC Marketing Awards 2022: What The Judges Said About The Leading Entries

The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?

Innovation Ad Campaigns

Haleon Voted Company Of The Year At The OTC Marketing Awards 2022

Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.

Ad Campaigns Launches

OTC Marketing Awards 2022 Just One Week Away

Don’t miss out on your chance to attend the OTC Marketing Awards 2022 in London on 28 November. Join us in celebrating innovation and creativity in the British consumer health industry.

United Kingdom Health
See All

Latest From Ad Complaints & Wellness

ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach

Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible." 

Ad Complaints United Kingdom

Responsibility For Distributors’ Claims At Root Of Supplement Direct Seller’s Advertising Review

After the DSSRC recommended that Root Wellness remove health claims from its advertising in 2021, the direct seller has not made efforts to remove the claims that its ambassadors have made on social media.

Regulation Enforcement

Sanofi Appealing Findings In Review Of Zantac 360 Doctor-Recommended Claims Challenged By J&J

French pharma disagrees with NAD finding, following review of a claims made in online and social media ads, retailers' websites and a TV commercial, that the claim “#1 doctor recommended medicine” for Zantac 360 refers to the brand and not famotidine, also used in other OTC heartburn remedies, including Pepcid.

Ad Complaints OTC Drugs
See All
UsernamePublicRestriction

Register